降钙素原
败血症
医学
感染性休克
抗生素治疗
重症监护医学
抗生素管理
抗生素
生物标志物
严重败血症
休克(循环)
内科学
抗生素耐药性
化学
微生物学
生物
生物化学
标识
DOI:10.3343/alm.2014.34.4.263
摘要
Procalcitonin (PCT) is used as a biomarker for the diagnosis of sepsis, severe sepsis and septic shock. At the same time, PCT has also been used to guide antibiotic therapy. This review outlines the main indications for PCT measurement and points out possible pitfalls. The classic indications for PCT measurement are: (i) confirmation or exclusion of diagnosis of sepsis, severe sepsis, or septic shock, (ii) severity assessment and follow up of systemic inflammation mainly induced by microbial infection, and (iii) individual, patient adapted guide of antibiotic therapy and focus treatment. Using serially monitored PCT levels, the duration and need of antibiotic therapy can be better adapted to the individual requirements of the patient. This individualized approach has been evaluated in various studies, and it is recommended to be a part of an antibiotic stewardship program.
科研通智能强力驱动
Strongly Powered by AbleSci AI